Prevalence of Overactive Bladder in U.S. Men Increased Significantly Since 2005

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 5, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 5, 2024 -- In the United States, the prevalence of overactive bladder (OAB) among men was 14.5 percent in 2015 to 2020, reflecting a significant increase from 2005, according to a study published online July 15 in Scientific Reports.

Yu Cheng, from the Jiangxi Medical College at Nanchang University in China, and colleagues examined the current prevalence and recent trends of OAB among U.S. adult men and assessed the correlations between OAB and potential risk factors using data from the National Health and Nutrition Examination Survey between 2005 and 2020. Trends in prevalence were examined from 2005 to 2008, 2009 to 2014, and 2015 to 2020.

The researchers found that the overall prevalence of OAB increased slightly from 11.3 to 11.7 percent in 2005-2008 to 2009-2014 and then increased significantly to 14.5 percent in 2015-2020. Stronger increases in prevalence were seen for those who were aged 40 to 59 years, non-Hispanic White and non-Hispanic Black individuals, and those with overweight and obesity. Independent risk factors for OAB included older age, non-Hispanic Black race, lower educational level and family poverty ratio, diabetes, depression, sleep disorder, other chronic comorbidities, less intense recreational activity, poorer health condition, and unsafe food.

"Future studies are needed to address OAB disparities across sociodemographic subgroups and to investigate the factors driving the rising trends in subtypes of OAB among older men, non-Hispanic White and Black, and obese men," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-06 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords